Internationally renowned R&D centers

With an open innovation model in mind, we have placed our three R&D centres at the heart of three internationally reputed scientific hubs: Paris-Saclay in France, Oxford in the United Kingdom and Cambridge in the United States, as well as sustaining contact with other leading academic research, medical and technology centres throughout the world .

We make sure we access the best information and opportunities provided through external networks; the partnerships that we develop through the surrounding scientific ecosystems contribute strongly to our R&D success.

The R&D center at Les Ulis is located in the Paris-Saclay hub, which is home to several thousand life science researchers. Ipsen’s innovation teams are housed in a high-tech environment, in close contact with major scientific and academic institutions, such as Ecole Polytechnique, the French National Center for Scientific Research (CNRS), the French National Institute of Health and Medical Research (INSERM) and the Atomic Energy Commission (CEA).

Established in 1969, one of the missions of Ipsen’s largest R&D site, is to accelerate clinical development and fundamental research to deepen our understanding of molecular, pharmacological, pharmacodynamic and pharmacokinetic properties of new molecules in Oncology, Neurology and Rare Diseases.

In January 2016, aligned with our open innovation strategy, Ipsen teamed up with Aepodia in a partnership covering early-stage development programmes in R&D. Aepodia is providing expertise in early clinical development and in the implementation of Phase I studies up to proof of concept (POC). Aepodia and Ipsen teams are working together to optimize the design of clinical studies and their operational implementation.

3

 

International R&D Centers

€265m

 

investment in R&D in 2017